Fig. 2: Kaplan-Meier survival curves for the lobaplatin-based therapy group and the cisplatin-based therapy group in the intention-to-treat population. | Nature Communications

Fig. 2: Kaplan-Meier survival curves for the lobaplatin-based therapy group and the cisplatin-based therapy group in the intention-to-treat population.

From: Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial

Fig. 2: Kaplan-Meier survival curves for the lobaplatin-based therapy group and the cisplatin-based therapy group in the intention-to-treat population.

A Progression-free Survival, B Overall Survival, C Locoregional Recurrence-free Survival, D Distant Metastasis-free Survival.

Back to article page